Stock Market Press Focus: Pet CBD with Metatron Expanding To Pet CBD; Other Companies Include Medial Marijuana, Isodiol and m...
New York, NY -- March 13, 2019 – InvestorsHub NewsWire -- Stock
Market Press (SMP) focuses on the rapidly growing Pet CBD market.
Companies covered in this spotlight include Medical Marijuana, Inc.
(OTC:
MJNA), Isodiol International Inc. (OTCQB:
ISOLF), mCig, Inc. (OTCQB:
MCIG) and Metatron, Inc. (OTC:
MRNJ)
With the recent passage and enactment of the 2018 Farm Bill, the
USA federal regulations on Hemp have been lifted, opening up the
doors to a hemp boom. Superior quality, along with increased
production, are seeing prices drop and more companies expanding
their CBD products to include the pet market. In the USA alone, the
general pet market is expected to have topped $72B for 2018, an
increase of almost 4% from 2017's $69.5B. With the advent of
increased Pet CBD products, 2019 could see a much larger increase.
Enter PetMojo and Metatron, Inc. (OTC:MRNJ)
Metatron, Inc. (OTC:MRNJ) just announced they have secured a deal
with PetMojo, a company with over 20 years experience in eCommerce
and 15 years experience running luxury pet services businesses.
Through their combined talents, PetMojo and Metatron, Inc.
(OTC:MRNJ) are going to develop and market a new Pet CBD product
sales App for both iTunes and Google Play users.
“Pet-and-animal product CBD sales are estimated to reach $125
million by 2022, representing a 5-year CAGR of 57 percent, among
the fastest-growing sectors in the CBD market.” - Metatron, Inc.
Press Release.
The pet CBD market is massive and mCig, Inc. (OTCQB: MCIG) recently
announced their expansion into CBD for pets. “CBD can help animals
in many of the same ways that it helps humans: improving arthritis,
immunity, anxiety, and digestion, and even with more serious
conditions, like broken bones and post-operative care,” says Arkady
Uryash, MD, PhD, head of MCIG’s Research and Development Department
– mCig press release
Isodiol International Inc. (OTCQB: ISOLF) another CBD focused
company has seen the potential boost in revenues that a pet CBD
line could provide and announced plans to enter the pet
industry.
Medical Marijuana, Inc. (OTC: MJNA) subsidiary Phyto Animal Health
CEO's Ian Quinn and his dog Dante the Pitt Bull, who takes CBD,
were at the HempMeds® booth showcasing the company's line of CBD
hemp oil supplements and hemp products for cats, dogs and horses.
“CBD hemp oil has been researched by top veterinarians for
cardiovascular, pain management, orthopedic, and mental health in
animals.” - Medical Marijuana Press Release
Metatron, Inc. (OTC:MRNJ) is tapping into another huge market,
increasing both their product exposure as well as revenues, since
the majority of CBD pet products are sold online.
Stock Market Press is a financial news company that delivers up
to date stock news, introduces private and public companies to a
wide audience of investors, consumers, journalists and the general
public via social media and a rapidly expanding network.
Contact:
Stock Market Press
110 Wall St.
New York, NY 10005
info@stockmarketpress.com
https://twitter.com/PressStock
Safe Harbor Statement:
Statements in this news release may be ''forward-looking
statements.'' Forward-looking statements include, but are not
limited to, statements that express our intentions, beliefs,
expectations, strategies, predictions or any other statements
relating to our future activities or other future events or
conditions. These statements are based on current expectations,
estimates and projections about our business based, in part, on
assumptions made by management. These statements are not guarantees
of future performance and involve risks, uncertainties and
assumptions that are difficult to predict. Therefore, actual
outcomes and results may, and are likely to, differ materially from
what is expressed or forecasted in forward-looking statements due
to numerous factors. Any forward-looking statements speak only as
of the date of this news release and Stock Market Press undertakes
no obligation to update any forward-looking statement to reflect
events or circumstances after the date of this news
release.
See Stock Market Press disclaimer: http://stockmarketpress.com/disclaimer/
SOURCE: Stock Market Press
Isodiol (CE) (USOTC:ISOLF)
過去 株価チャート
から 11 2024 まで 12 2024
Isodiol (CE) (USOTC:ISOLF)
過去 株価チャート
から 12 2023 まで 12 2024